Abstract
The eye and the skin are protected by a multi-layered epithelial barrier that provides the first line of defence against invading pathogens and environmental stresses such as damaging solar ultraviolet radiation. Extensive epidemiological findings supported by compelling experimental evidence in culture and animal models suggest that ultraviolet radiation is the most important environmental carcinogen leading to the development of a variety of benign and malignant ocular and cutaneous conditions. Epithelial cells have evolved several key defence mechanisms to prevent ultraviolet radiation-induced DNA mutations from stably entering the genome and ultraviolet radiation-damaged cells from establishing themselves in an otherwise normal microenvironment. Firstly, through the process excision repair, cells have the ability to correct carcinogen-induced DNA damage. Secondly, severely damaged cells are eliminated from healthy tissues by molecular programs that trigger cell death. These processes are activated through complex intracellular signalling circuits that ensure that organs such as the eyes and skin are maintained in a disease-free state. Finally, abnormal cells can be recognized, targeted and destroyed by surveillance from the immune system, however this is complicated further by the immunosuppressive effects of ultraviolet radiation that promote tumour growth. This review will discuss in greater detail some of the processes and pathways that are activated in response to ultraviolet radiation and their effect on ocular and cutaneous health.
Keywords: Apoptosis, conjunctival neoplasia, eye, MAPKs, pterygium, receptors, signalling, skin
Current Pharmaceutical Design
Title: Signalling Pathways Activated by Ultraviolet Radiation: Role in Ocular and Cutaneous Health
Volume: 16 Issue: 12
Author(s): Nick Di Girolamo
Affiliation:
Keywords: Apoptosis, conjunctival neoplasia, eye, MAPKs, pterygium, receptors, signalling, skin
Abstract: The eye and the skin are protected by a multi-layered epithelial barrier that provides the first line of defence against invading pathogens and environmental stresses such as damaging solar ultraviolet radiation. Extensive epidemiological findings supported by compelling experimental evidence in culture and animal models suggest that ultraviolet radiation is the most important environmental carcinogen leading to the development of a variety of benign and malignant ocular and cutaneous conditions. Epithelial cells have evolved several key defence mechanisms to prevent ultraviolet radiation-induced DNA mutations from stably entering the genome and ultraviolet radiation-damaged cells from establishing themselves in an otherwise normal microenvironment. Firstly, through the process excision repair, cells have the ability to correct carcinogen-induced DNA damage. Secondly, severely damaged cells are eliminated from healthy tissues by molecular programs that trigger cell death. These processes are activated through complex intracellular signalling circuits that ensure that organs such as the eyes and skin are maintained in a disease-free state. Finally, abnormal cells can be recognized, targeted and destroyed by surveillance from the immune system, however this is complicated further by the immunosuppressive effects of ultraviolet radiation that promote tumour growth. This review will discuss in greater detail some of the processes and pathways that are activated in response to ultraviolet radiation and their effect on ocular and cutaneous health.
Export Options
About this article
Cite this article as:
Di Girolamo Nick, Signalling Pathways Activated by Ultraviolet Radiation: Role in Ocular and Cutaneous Health, Current Pharmaceutical Design 2010; 16 (12) . https://dx.doi.org/10.2174/138161210791033923
DOI https://dx.doi.org/10.2174/138161210791033923 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Polyglandular Autoimmune Syndromes
Current Immunology Reviews (Discontinued) Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic
Current Drug Metabolism TRP Channels: New Potential Therapeutic Approaches in CNS Neuropathies
CNS & Neurological Disorders - Drug Targets Synergistic Antiproliferative and Antiangiogenic Effects of EGFR and mTOR Inhibitors
Current Pharmaceutical Design Treatment for Diabetic Peripheral Neuropathy: What have we Learned from Animal Models?
Current Diabetes Reviews Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer
Reviews on Recent Clinical Trials Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery Cross-Talk between Oxidative Stress and Pro-Inflammatory Cytokines in Acute Pancreatitis: A Key Role for Protein Phosphatases
Current Pharmaceutical Design PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Current Drug Targets Methionine Aminopeptidases as Potential Targets for Treatment of Gastrointestinal Cancers and other Tumors
Current Drug Targets Metformin as a Radiation Modifier; Implications to Normal Tissue Protection and Tumor Sensitization
Current Clinical Pharmacology Membrane and Soluble Forms of Endoglin in Preeclampsia
Current Molecular Medicine Nanotechology-Based Strategies to Enhance the Efficacy of Photodynamic Therapy for Cancers
Current Drug Metabolism Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery One Hundred Faces of Cyclopamine
Current Pharmaceutical Design Improvement of Nonviral Gene Therapy by Epstein-Barr Virus (EBV)-based Plasmid Vectors
Current Gene Therapy Global Cell Proteome Profiling, Phospho-signaling and Quantitative Proteomics for Identification of New Biomarkers in Acute Myeloid Leukemia Patients
Current Pharmaceutical Biotechnology Regulation of Transcription Factors by Heterotrimeric G Proteins
Current Molecular Pharmacology In Vitro and In Vivo Performance of Novel Spray Dried Andrographolide Loaded Scleroglucan Based Formulation for Dry Powder Inhaler
Current Drug Delivery Mechanisms of Cytotoxicity of Anticancer Titanocenes
Anti-Cancer Agents in Medicinal Chemistry